Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

By Paz-Ares Luis  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 729-740

Springer Publishing Company

Access to resources Recommend Favorite

A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial

By Knowling M.   Blackstein M.   Tozer R.   Bramwell V.   Dancey J.   Dore N.   Matthews S.   Eisenhauer E.  

Investigational New Drugs, Vol. 24, Iss. 5, 2006-09 ,pp. : 435-439

Springer Publishing Company

Access to resources Recommend Favorite

Phase I trial of sorafenib in combination with ifosfamide in patients with advanced sarcoma: a Spanish group for research on sarcomas (GEIS) study

By Martín-Liberal J.   López-Pousa A.   Broto J.   Cubedo R.   Gallego O.   Brendel E.   Tirado O.   Muro X.  

Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. : 287-294

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality-of-life results from PALETTE: A randomized, double-blind, phase 3 trial of pazopanib versus placebo in patients with soft tissue sarcoma whose disease has progressed during or after prior chemotherapy—a European Organization for research and treatment of cancer soft tissue and bone sarcoma group global network study (EORTC 62072)

By  

Cancer, Vol. 121, Iss. 17, 2015-09 ,pp. : 2933-2941

Blackwell Publishing

Access to resources Recommend Favorite

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

By Reichardt Peter   Oechsle Karin   Pink Daniel   Bokemeyer Carsten   Schneller F.   Issels Rolf   Kanz Lothar   Hartmann Jörg Thomas  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 481-486

Springer Publishing Company

Access to resources Recommend Favorite